Revolutionizing Eye Care for Rare Diseases

We're focused on delivering healing to those who need it most

At Eliksa, we're at the forefront of biotechnological advancements to address unmet needs in eye care. Our exclusive products leverage the regenerative potential of specialized biological components, fostering healing for ocular conditions. Each product undergoes meticulous processing in our state-of-the-art cGMP regenerative medicine facility, ensuring a consistent acellular solution while preserving the vital biological components.

Eyes on Tomorrow

Paving the Path for EB Ocular Care

We're on a transformative journey in regenerative medicine, with a particular focus on the ocular manifestations of Epidermolisis Bullosa (EB), an ultra-rare genetic disorder that primarily affects children. ELK-003, our groundbreaking investigational ophthalmic drug, delivered in the form of eye drops, represents a pioneering step towards addressing this longstanding, unmet need.

OUR MANUFACTURING

cGMP research and commercial manufacturing facility

Our cGMP facility has perfected their specialized processing and sterilization methods for our proprietary biological product, ensuring consistent biological activity for therapeutic applications.